Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Braveheart BioBRVE -2.72%8 FCF Yield % is -16,900.00 as of Aug. 09, 2026. GuruFocus rates BRVE with a GF Score™ of 8/100. Among 1,408 Biotechnology companies, Braveheart Bio ranks worse than 99.43% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Braveheart Bio FCF Yield % Related Terms
Braveheart Bio FCF Yield % Historical Data
* Premium members only.
The historical data trend for Braveheart Bio's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Braveheart Bio FCF Yield % Chart
Braveheart Bio Annual Data
Trend
Dec25
FCF Yield %
0.00
Braveheart Bio Semi-Annual Data
Dec25
FCF Yield %
0.00
BRVE vs : FCF Yield % Comparison
For the Biotechnology subindustry, Braveheart Bio's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Braveheart Bio FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Braveheart Bio's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Braveheart Bio's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Braveheart Bio (BRVE) has a FCF Yield % of -16,900.00 as of Aug. 09, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Braveheart Bio and its competitors. According to the industry distribution chart, Braveheart Bio ranks #1400 out of 1408 companies in the Biotechnology industry, placing it in the top 99.4%.
Is Braveheart Bio's FCF Yield % too high?
Braveheart Bio's current FCF Yield % is -16,900.00. Based on the distribution chart, Braveheart Bio ranks #1400 out of 1408 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Braveheart Bio has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Braveheart Bio's FCF Yield % compare to ?
According to the Biotechnology industry distribution chart, Braveheart Bio ranks #1400 out of 1408 companies for FCF Yield %. This places Braveheart Bio in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Braveheart Bio and its competitors. Braveheart Bio's current FCF Yield % is -16,900.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Braveheart Bio stock overvalued right now?
Braveheart Bio (BRVE) has a current FCF Yield % of -16,900.00. The current FCF Yield % is -16,900.00. Braveheart Bio's overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Braveheart Bio (BRVE), the current FCF Yield % is -16,900.00 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases. Its flagship product candidate, BHB-1893, is an oral small-molecule cardiac myosin inhibitor being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM).
8GF Score
Get the complete analysis for BRVE
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BRVE has been successfully added to your 
